カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

フローサイトメトリーの世界市場予測（～2028）：技術別、製品＆サービス別、用途別、エンドユーザー別、地域別

◆英語タイトル：Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End User & Region - Global Forecast to 2028
	◆商品コード：BT6015-23 ◆発行会社（リサーチ会社）：MarketsandMarkets ◆発行日：2023年8月20日 ◆ページ数：397 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後24時間以内） ◆調査対象地域：グローバル ◆産業分野：バイオテクノロジー

◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥742,500	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥997,500	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,222,500	見積依頼/購入/質問フォーム

★MarketsandMarketsに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

"世界のフローサイトメトリー市場は、2023年の47億米ドルから2028年には70億米ドルに達し、予測期間中のCAGRは8.3％と予測" HIV/AIDS、癌、自己免疫疾患の世界的な有病率の上昇、臨床アプリケーションへのフローサイトメトリーの採用の増加は、セグメントの成長を予測する主な要因の一部です。さらに、主要な市場プレーヤーによる技術的に先進的なフローサイトメトリー製品の発売は、市場成長をさらに促進する可能性があります。2021年11月、Bio-Rad Laboratories, Inc.（米国）は、フローサイトメトリーアプリケーションでUVレーザーを使用するために設計された蛍光ナノ粒子、StarBright UltraViolet 400 Dyeを発売しました。

"細胞ベースのフローサイトメトリーは、2023～2028年の予測期間中に大きなCAGRで成長すると予測"
技術に基づいて、フローサイトメトリー市場はセルベースフローサイトメトリーとビーズベースフローサイトメトリーです。2022年にはセルベースフローサイトメトリーセグメントが市場を支配しました。この優位性は、技術的に高度なセルベースフローサイトメトリー製品の存在に起因します。ビーズベースフローサイトメトリーは、今後数年で大きなペースで成長する可能性が高いです。ビーズベースフローサイトメトリーの採用が増加していること、主要市場企業がビーズベースフローサイトメトリーの発売に力を入れていることが、市場成長にプラスの影響を与えそうです。

"2022年は研究用途セグメントが市場を支配"
エンドユーザーに基づき、フローサイトメトリー市場は研究アプリケーション、臨床アプリケーション、産業アプリケーションに区分。研究用途がセグメントを支配しました。しかし、臨床アプリケーションは予測期間中に大きなCAGRで成長すると予測されています。臨床および研究用途での産学連携は、市場にプラスの影響を与えるでしょう。例えば、2023年3月、BDとシンガポールの科学技術研究庁（A*STAR）は、スペクトルフローサイトメトリーパネルを用いたヒト組織の深部免疫フェノタイピングに焦点を当て、医療の成果につながる発見をもたらす研究パートナーシップを締結しました。

"2022年は北米が圧倒的シェア"
地域的には、フローサイトメトリー市場は、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカに区分されます。2022年、北米がフローサイトメトリー市場の主要シェアを占めました。北米地域の優位性は、同地域における主要市場プレイヤーの存在、同地域における研究アプリケーションでのフローサイトメトリー採用の増加など、さまざまな要因によるものです。アジア太平洋地域は、研究資金の増加や幹細胞および臨床研究への注目の高まりにより、より速いペースで成長する見込みです。

本レポートのために実施した一次インタビューは以下のように分類できます：
- 回答者別：供給側70%、需要側30%
- 役職別：Cレベル45％、Dレベル30％、その他25%
- 地域別：北米：40％、欧州：25％、アジア太平洋地域：20％、中南米：10％、中東・アフリカ：5%

レポート掲載企業一覧
• BD (US)
• Danaher Corporation (US)
• Thermo Fisher Scientific, Inc. (US)
• Agilent Technologies, Inc. (US)
• Sony Corporation (Japan)
• Bio-Rad Laboratories, Inc. (US)
• Miltenyi Biotec (Germany)
• Enzo Biochem, Inc. (US)
• Sysmex Corporation (Japan)
• bioMérieux (France)
• Cytonome/ST, LLC (US)
• Sartorius AG (Germany)
• Cytek Biosciences (US)
• Union Biometrica, Inc. (US)
• Luminex Corporation (Italy)
• Apogee Flow Systems Ltd. (UK)
• Stratedigm, Inc. (US)
• NanoCellect Biomedical, Inc. (US)
• On-chip Biotechnologies, Co., Ltd. (Japan)
• Nexcelom Biosciences LLC. (US)
• BennuBio Inc. (US)
• Orflo Technologies (US)
• Bay Biosciences Co., Ltd. (Japan)
• BioLegend, Inc. (US)
• CytoBuoy B.V (Netherlands)

調査範囲
本レポートはフローサイトメトリー市場の詳細な情報を提供します。技術、製品＆サービス、アプリケーション、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要な市場プレイヤーの会社概要、最近の動向、主要な市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します：
- 主要推進要因の分析（HIV/AIDSおよび癌の罹患率の上昇、創薬および薬剤開発のための研究における幅広いアプリケーション、再生医療におけるフローサイトメトリーの使用、免疫学および免疫腫瘍学研究における官民イニシアチブの拡大、フローサイトメトリー装置の技術的進歩）、市場成長に影響を与える阻害要因（高価格製品）、機会（新興経済国、幹細胞研究への注目の高まり、抗体産生用組換えDNA技術の普及）、課題（試薬開発に関する複雑さ、熟練専門家の不足）
- 製品とサービスの開発/革新：フローサイトメトリー市場の新発売製品や技術評価に関する詳細な洞察
- 市場開発：有利な市場に関する包括的な情報 - 様々な地域の市場を分析
- 市場の多様化：フローサイトメトリー市場における新製品、未開拓の地域、最近の開発、投資に関する詳細な情報
- 競合評価：BD (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Sony Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec (Germany), Enzo Biochem, Inc. (US), Sysmex Corporation (Japan), bioMérieux (France), Cytonome/ST, LLC (US), Sartorius AG (Germany), Cytek Biosciences (US), Union Biometrica, Inc. (US), Luminex Corporation (Italy), Apogee Flow Systems Ltd. (UK), Stratedigm, Inc. (US), NanoCellect Biomedical, Inc. (US), On-chip Biotechnologies, Co., Ltd. (Japan), Nexcelom Biosciences LLC. (US), BennuBio Inc. (US), Orflo Technologies (US), Bay Biosciences Co., Ltd. (Japan), BioLegend, Inc. (US), and CytoBuoy B.V (Netherlands)などの主要企業の市場シェア、成長戦略、サービス提供などを詳細に評価

1. イントロダクション
2. 調査方法
3. エグゼクティブサマリー
4. プレミアムインサイト
5. 市場概要
6. フローサイトメトリー市場：技術別
7. フローサイトメトリー市場：製品・サービス別
8. フローサイトメトリー市場：用途別
9. フローサイトメトリー市場：エンドユーザー別
10. フローサイトメトリー市場：地域別
11. 競争状況
12. 企業情報
13. 付録

❖ レポートの目次 ❖

1 INTRODUCTION 55
1.1 STUDY OBJECTIVES 55
1.2 MARKET DEFINITION 55
1.2.1 INCLUSIONS AND EXCLUSIONS 56
1.3 MARKET SCOPE 56
1.3.1 MARKETS COVERED 56
1.3.2 YEARS CONSIDERED 57
1.4 CURRENCY CONSIDERED 57
1.5 RESEARCH LIMITATIONS 57
1.6 STAKEHOLDERS 58
1.7 SUMMARY OF CHANGES 58
1.8 RECESSION IMPACT 59
2 RESEARCH METHODOLOGY 60
2.1 RESEARCH DATA 60
FIGURE 1 RESEARCH DESIGN 60
2.1.1 SECONDARY DATA 61
2.1.2 PRIMARY DATA 62
FIGURE 2 FLOW CYTOMETRY MARKET: BREAKDOWN OF PRIMARIES 62
2.2 MARKET SIZE ESTIMATION 63
FIGURE 3 FLOW CYTOMETRY MARKET: MARKET SIZE ESTIMATION FOR SUPPLY SIDE ANALYSIS (2022) 63
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS) FOR 2022 64
FIGURE 5 ILLUSTRATIVE EXAMPLE OF BD: REVENUE SHARE ANALYSIS (2022) 64
2.2.1 PRIMARY INSIGHTS 66
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 66
2.2.2 MARKET SIZE ESTIMATION METHODOLOGY 66
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 66
2.3 GROWTH RATE ASSUMPTIONS 67
FIGURE 8 FLOW CYTOMETRY MARKET: CAGR PROJECTIONS DURING FORECAST PERIOD 68
FIGURE 9 FLOW CYTOMETRY MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 68
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 69
FIGURE 10 DATA TRIANGULATION METHODOLOGY 69
2.5 STUDY ASSUMPTIONS 70
2.6 RISK ANALYSIS 70
2.7 RECESSION IMPACT ANALYSIS 70
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2024–2028 (% GROWTH) 71
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 71
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 71
3 EXECUTIVE SUMMARY 72
FIGURE 11 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 72
FIGURE 12 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 73
FIGURE 13 FLOW CYTOMETRY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 73
FIGURE 14 FLOW CYTOMETRY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 74
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF FLOW CYTOMETRY MARKET 75
4 PREMIUM INSIGHTS 76
4.1 FLOW CYTOMETRY MARKET OVERVIEW 76
FIGURE 16 RISING NEED FOR RESEARCH APPLICATIONS IN DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET 76
4.2 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE AND COUNTRY 77
FIGURE 17 REAGENTS & CONSUMABLES SEGMENT IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 77
4.3 FLOW CYTOMETRY MARKET SHARE, BY TECHNOLOGY, 2023 VS. 2028 78
FIGURE 18 CELL-BASED FLOW CYTOMETRY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 78
4.4 FLOW CYTOMETRY MARKET SHARE, BY END USER 78
FIGURE 19 ACADEMIC & RESEARCH INSTITUTES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 78
4.5 FLOW CYTOMETRY MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 79
FIGURE 20 CHINA PROJECTED TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 79
5 MARKET OVERVIEW 80
5.1 INTRODUCTION 80
5.2 MARKET DYNAMICS 80
FIGURE 21 FLOW CYTOMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 80
5.2.1 DRIVERS 81
5.2.1.1 Rising incidence of HIV/AIDS and cancer 81
TABLE 4 INCIDENCE OF HIV/AIDS, BY REGION (2022) 81
TABLE 5 GLOBAL CANCER INCIDENCE, 2020 VS. 2040 81
5.2.1.2 Wide applications in research for drug discovery & development 82
5.2.1.3 Use of flow cytometry in regenerative medicine 83
5.2.1.4 Growing public-private initiatives in immunology and immuno-oncology research 84
5.2.1.5 Technological advancements in flow cytometry instruments 85
TABLE 6 KEY TECHNOLOGICAL ADVANCEMENTS (2019–2022) 85
5.2.2 RESTRAINTS 87
5.2.2.1 High product pricing 87
5.2.3 OPPORTUNITIES 87
5.2.3.1 High growth potential in emerging economies 87
5.2.3.2 Rising focus on stem cell research 88
TABLE 7 ESTIMATED EXPENDITURE BY NIH FOR STEM CELL RESEARCH (2019−2024) 88
5.2.3.3 Uptake of recombinant DNA technology for antibody production 89
5.2.4 CHALLENGES 89
5.2.4.1 Complexities related to reagent development 89
5.2.4.2 Shortage of skilled professionals 89
5.3 SUPPLY CHAIN ANALYSIS 90
FIGURE 22 DIRECT DISTRIBUTION STRATEGY PREFERRED BY PROMINENT COMPANIES 91
5.4 VALUE CHAIN ANALYSIS 91
FIGURE 23 FLOW CYTOMETRY MARKET: VALUE CHAIN ANALYSIS 91
5.5 ECOSYSTEM ANALYSIS 92
FIGURE 24 FLOW CYTOMETRY MARKET: ECOSYSTEM MAP 92
5.5.1 ECOSYSTEM ROLE 92
5.6 REGULATORY ASSESSMENT 93
5.6.1 STRINGENT FDA REQUIREMENTS 93
5.6.2 ANALYTE-SPECIFIC REAGENT RULE 93
5.6.3 LIMITATIONS IN VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS 93
5.6.4 ABSENCE OF GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS 93
5.6.5 IVD CE MARK APPROVALS 94
5.6.6 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
5.6.7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER BODIES 95
5.6.8 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
5.6.9 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
5.6.10 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 12 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
5.7 PORTER’S FIVE FORCES ANALYSIS 98
TABLE 13 FLOW CYTOMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS 98
5.7.1 INTENSITY OF COMPETITIVE RIVALRY 98
5.7.2 BARGAINING POWER OF SUPPLIERS 98
5.7.3 BARGAINING POWER OF BUYERS 99
5.7.4 THREAT OF SUBSTITUTES 99
5.7.5 THREAT OF NEW ENTRANTS 99
5.8 PATENT ANALYSIS 100
5.8.1 LIST OF MAJOR PATENTS 101
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 102
FIGURE 25 RISING USE OF FLOW CYTOMETRY IN CLINICAL APPLICATIONS TO DRIVE MARKET 102
5.10 PRICING ANALYSIS 102
5.10.1 AVERAGE SELLING PRICE OF FLOW CYTOMETERS, BY TYPE 102
TABLE 14 COST OF FLOW CYTOMETERS, BY TYPE 102
5.10.2 COST OF FLOW CYTOMETERS AND OTHER PRODUCTS, BY KEY PLAYERS 103
TABLE 15 COST OF FLOW CYTOMETERS AND OTHER PRODUCTS, BY KEY PLAYERS 103
5.10.3 COST OF FLOW CYTOMETRY SOFTWARE 103
5.10.4 AVERAGE SELLING PRICE FOR FLOW CYTOMETRY INSTRUMENTS 103
5.11 KEY CONFERENCES AND EVENTS 104
TABLE 16 FLOW CYTOMETRY MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024) 104
5.12 TRADE DATA 104
TABLE 17 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017-2021 (USD THOUSAND) 104
TABLE 18 EXPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2017–2021 (USD THOUSAND) 105
TABLE 19 IMPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2022 (USD THOUSAND) 106
TABLE 20 EXPORT DATA FOR FLOW CYTOMETERS, BY COUNTRY, 2022 (USD THOUSAND) 107
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 108
FIGURE 26 KEY STAKEHOLDERS IN BUYING PROCESS 108
FIGURE 27 KEY BUYING CRITERIA FOR FLOW CYTOMETRY PRODUCTS AMONG END USERS 109
6 FLOW CYTOMETRY MARKET, BY TECHNOLOGY 110
6.1 INTRODUCTION 111
TABLE 21 FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 111
6.2 CELL-BASED FLOW CYTOMETRY 111
6.2.1 RISING R&D INVESTMENTS FOR NEW THERAPEUTIC AGENTS TO DRIVE MARKET 111
TABLE 22 CELL-BASED FLOW CYTOMETRY MARKET, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 23 NORTH AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 24 EUROPE: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 25 ASIA PACIFIC: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 26 LATIN AMERICA: CELL-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
6.3 BEAD-BASED FLOW CYTOMETRY 114
6.3.1 ABILITY TO OFFER HIGH RELIABILITY AND CONSISTENT MEASUREMENT TO SUPPORT MARKET GROWTH 114
FIGURE 28 BEAD-BASED FLOW CYTOMETRY MARKET: MARKET SHARE ANALYSIS (2022) 115
TABLE 27 BEAD-BASED FLOW CYTOMETRY MARKET, BY REGION, 2021–2028 (USD MILLION) 115
TABLE 28 NORTH AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 29 EUROPE: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 30 ASIA PACIFIC: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 31 LATIN AMERICA: BEAD-BASED FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
7 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE 118
7.1 INTRODUCTION 119
TABLE 32 FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 119
7.2 REAGENTS & CONSUMABLES 119
7.2.1 RECURRING REQUIREMENT OF CONSUMABLES AND DEVELOPMENT OF HIGH-QUALITY REAGENTS TO DRIVE MARKET 119
TABLE 33 FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 34 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 35 EUROPE: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 36 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 37 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION) 122
7.3 INSTRUMENTS 122
TABLE 38 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 39 FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 40 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 41 EUROPE: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 42 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 43 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INSTRUMENTS, BY COUNTRY, 2021–2028 (USD MILLION) 125
7.3.1 CELL ANALYZERS 125
TABLE 44 FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY PRICE RANGE, 2021–2028 (USD MILLION) 126
TABLE 45 FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION) 126
TABLE 46 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 47 EUROPE: FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 48 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 49 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 128
7.3.1.1 High-range cell analyzers 129
7.3.1.1.1 Advantages of higher sensitivity and accuracy to drive adoption among end users 129
TABLE 50 FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 51 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 52 EUROPE: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 53 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 130
TABLE 54 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 131
7.3.1.2 Mid-range cell analyzers 131
7.3.1.2.1 Availability of compact & high-performance analyzers to support market growth 131
TABLE 55 FLOW CYTOMETRY MARKET FOR MID-RANGE CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION) 131
TABLE 56 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 57 EUROPE: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 58 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 59 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 133
7.3.1.3 Low-range cell analyzers 133
7.3.1.3.1 High adoption among price-sensitive end users to propel market 133
TABLE 60 FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL ANALYZERS, BY REGION, 2021–2028 (USD MILLION) 134
TABLE 61 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 62 EUROPE: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 63 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 135
TABLE 64 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL ANALYZERS, BY COUNTRY, 2021–2028 (USD MILLION) 136
7.3.2 CELL SORTERS 136
TABLE 65 FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY PRICE RANGE, 2021–2028 (USD MILLION) 137
TABLE 66 FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY REGION, 2021–2028 (USD MILLION) 137
TABLE 67 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 68 EUROPE: FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 69 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 138
TABLE 70 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 139
7.3.2.1 High-range cell sorters 139
7.3.2.1.1 High adoption among core laboratories due to procedural benefits to drive market 139
TABLE 71 FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL SORTERS, BY REGION, 2021–2028 (USD MILLION) 139
TABLE 72 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 73 EUROPE: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 74 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 75 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HIGH-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 141
7.3.2.2 Mid-range cell sorters 141
7.3.2.2.1 Cost-efficiency and frequent product launches to drive market 141
TABLE 76 FLOW CYTOMETRY MARKET FOR MID-RANGE CELL SORTERS, BY REGION, 2021–2028 (USD MILLION) 142
TABLE 77 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 142
TABLE 78 EUROPE: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 79 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 143
TABLE 80 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR MID-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 144
7.3.2.3 Low-range cell sorters 144
7.3.2.3.1 Increasing use in small labs and research facilities to drive market 144
TABLE 81 FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL SORTERS, BY REGION, 2021–2028 (USD MILLION) 144
TABLE 82 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 83 EUROPE: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 84 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 145
TABLE 85 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR LOW-RANGE CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION) 146
7.4 SERVICES 146
7.4.1 ABILITY TO ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE TO DRIVE MARKET 146
TABLE 86 FLOW CYTOMETRY MARKET FOR SERVICES, BY REGION, 2021–2028 (USD MILLION) 147
TABLE 87 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 88 EUROPE: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 89 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 148
TABLE 90 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 148
7.5 SOFTWARE 149
7.5.1 GROWING AVAILABILITY OF TECHNOLOGICALLY ADVANCED DATA ANALYSIS SOFTWARE TO DRIVE MARKET 149
TABLE 91 FLOW CYTOMETRY MARKET FOR SOFTWARE, BY REGION, 2021–2028 (USD MILLION) 149
7.6 ACCESSORIES 150
7.6.1 PROCEDURAL BENEFITS OF CUSTOMIZATION AND UPGRADES TO SUPPORT MARKET GROWTH 150
TABLE 92 FLOW CYTOMETRY MARKET FOR ACCESSORIES, BY REGION, 2021–2028 (USD MILLION) 150
8 FLOW CYTOMETRY MARKET, BY APPLICATION 151
8.1 INTRODUCTION 152
TABLE 93 FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
8.2 RESEARCH APPLICATIONS 152
TABLE 94 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 95 FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 153
TABLE 96 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 97 EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 154
TABLE 98 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 155
TABLE 99 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 155
8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY 156
TABLE 100 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 101 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2021–2028 (USD MILLION) 156
TABLE 102 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 103 EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 157
TABLE 104 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 158
TABLE 105 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 158
8.2.1.1 Drug discovery 159
8.2.1.1.1 Growing use of phenotypic cell-based assays in drug discovery to drive market 159
TABLE 106 FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY REGION, 2021–2028 (USD MILLION) 160
TABLE 107 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 108 EUROPE: FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 109 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 161
TABLE 110 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021–2028 (USD MILLION) 162
8.2.1.2 Stem cell research 162
8.2.1.2.1 Rising incidence of cancer to propel market 162
TABLE 111 FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY REGION, 2021–2028 (USD MILLION) 163
TABLE 112 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 163
TABLE 113 EUROPE: FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 114 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 164
TABLE 115 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 165
8.2.1.3 In vitro toxicity testing 165
8.2.1.3.1 Rising need to curtail drug attrition rates to support market growth 165
TABLE 116 FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY REGION, 2021–2028 (USD MILLION) 166
TABLE 117 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 118 EUROPE: FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 166
TABLE 119 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 167
TABLE 120 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR IN VITRO TOXICITY TESTING, BY COUNTRY, 2021–2028 (USD MILLION) 167
8.2.2 IMMUNOLOGY 167
8.2.2.1 Increasing prevalence of infectious & autoimmune diseases to drive market 167
TABLE 121 FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY REGION, 2021–2028 (USD MILLION) 168
TABLE 122 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 168
TABLE 123 EUROPE: FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 124 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 169
TABLE 125 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR IMMUNOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 170
8.2.3 CELL SORTING 170
8.2.3.1 Development of technologically advanced cell sorters to drive market 170
TABLE 126 FLOW CYTOMETRY MARKET FOR CELL SORTING, BY REGION, 2021–2028 (USD MILLION) 171
TABLE 127 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 128 EUROPE: FLOW CYTOMETRY MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION) 171
TABLE 129 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 130 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL SORTING, BY COUNTRY, 2021–2028 (USD MILLION) 172
8.2.4 APOPTOSIS 173
8.2.4.1 Wide availability of apoptosis assays to support market growth 173
TABLE 131 FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY REGION, 2021–2028 (USD MILLION) 173
TABLE 132 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION) 173
TABLE 133 EUROPE: FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 134 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION) 174
TABLE 135 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR APOPTOSIS, BY COUNTRY, 2021–2028 (USD MILLION) 175
8.2.5 CELL CYCLE ANALYSIS 175
8.2.5.1 Ability to detect chromosomal abnormalities to propel market 175
TABLE 136 FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY REGION, 2021–2028 (USD MILLION) 175
TABLE 137 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 138 EUROPE: FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 176
TABLE 139 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 177
TABLE 140 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL CYCLE ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 177
8.2.6 CELL VIABILITY 178
8.2.6.1 Assessing physiological characteristics of specific target cells to support market growth 178
TABLE 141 FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY REGION, 2021–2028 (USD MILLION) 178
TABLE 142 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION) 178
TABLE 143 EUROPE: FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 144 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION) 179
TABLE 145 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL VIABILITY, BY COUNTRY, 2021–2028 (USD MILLION) 180
8.2.7 CELL COUNTING 180
8.2.7.1 Ability to simultaneously analyze additional parameters with high accuracy to drive market 180
TABLE 146 FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY REGION, 2021–2028 (USD MILLION) 181
TABLE 147 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 148 EUROPE: FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION) 181
TABLE 149 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 150 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CELL COUNTING, BY COUNTRY, 2021–2028 (USD MILLION) 182
8.2.8 OTHER RESEARCH APPLICATIONS 183
TABLE 151 FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 183
TABLE 152 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 183
TABLE 153 EUROPE: FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 154 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 184
TABLE 155 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 184
8.3 CLINICAL APPLICATIONS 185
TABLE 156 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 157 FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 185
TABLE 158 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 159 EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 186
TABLE 160 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 187
TABLE 161 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 187
8.3.1 CANCER 188
8.3.1.1 Rising use in prediction of cancer recurrence to drive market 188
TABLE 162 ESTIMATED NUMBER OF NEW CANCER CASES (2020 ─2040) 188
TABLE 163 FLOW CYTOMETRY MARKET FOR CANCER, BY REGION, 2021–2028 (USD MILLION) 189
TABLE 164 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 165 EUROPE: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 189
TABLE 166 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 190
TABLE 167 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 190
8.3.2 HEMATOLOGY 191
8.3.2.1 Assessment in hematopoiesis and bone marrow function to drive market 191
TABLE 168 FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY REGION, 2021–2028 (USD MILLION) 191
TABLE 169 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 191
TABLE 170 EUROPE: FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 171 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 192
TABLE 172 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION) 193
8.3.3 IMMUNODEFICIENCY DISEASES 193
8.3.3.1 Detection of HIV infection and analysis of antigen-specific T-cells to propel market 193
TABLE 173 APPLICATION OF FLOW CYTOMETRY IN DIAGNOSIS OF PRIMARY IMMUNODEFICIENCY DISEASES 194
TABLE 174 FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASES, BY REGION, 2021–2028 (USD MILLION) 195
TABLE 175 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 176 EUROPE: FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 196
TABLE 177 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 197
TABLE 178 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR IMMUNODEFICIENCY DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 197
8.3.4 ORGAN & TISSUE TRANSPLANTATION 197
8.3.4.1 Detection of specific antibodies for donor selection to drive market 197
TABLE 179 FLOW CYTOMETRY MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY REGION, 2021–2028 (USD MILLION) 198
TABLE 180 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION) 198
TABLE 181 EUROPE: FLOW CYTOMETRY MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 182 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION) 199
TABLE 183 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ORGAN & TISSUE TRANSPLANTATION, BY COUNTRY, 2021–2028 (USD MILLION) 200
8.3.5 OTHER CLINICAL APPLICATIONS 200
TABLE 184 FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 200
TABLE 185 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 186 EUROPE: FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 187 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 201
TABLE 188 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 202
8.4 INDUSTRIAL APPLICATIONS 202
8.4.1 RISING USE IN ENERGY AND FOOD & DAIRY SECTORS TO SUPPORT MARKET GROWTH 202
TABLE 189 FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 203
TABLE 190 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 203
TABLE 191 EUROPE: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 203
TABLE 192 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 204
TABLE 193 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 204
9 FLOW CYTOMETRY MARKET, BY END USER 205
9.1 INTRODUCTION 206
TABLE 194 FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 206
9.2 ACADEMIC AND RESEARCH INSTITUTES 206
9.2.1 GROWING USE OF FLOW CYTOMETRY IN CANCER & STEM CELL RESEARCH TO DRIVE MARKET 206
TABLE 195 FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 207
TABLE 196 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 197 EUROPE: FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 208
TABLE 198 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 209
TABLE 199 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 209
9.3 HOSPITALS AND CLINICAL TESTING LABORATORIES 210
9.3.1 RISING USE IN CLINICAL APPLICATIONS FOR INFECTIOUS DISEASE DIAGNOSTICS TO PROPEL MARKET 210
TABLE 200 FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 210
TABLE 201 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 202 EUROPE: FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 211
TABLE 203 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 212
TABLE 204 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 212
9.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 213
9.4.1 INCREASING NUMBER OF CLINICAL TRIALS TO SUPPORT MARKET GROWTH 213
TABLE 205 FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 213
TABLE 206 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 207 EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 214
TABLE 208 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 215
TABLE 209 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 215
10 FLOW CYTOMETRY MARKET, BY REGION 216
10.1 INTRODUCTION 217
TABLE 210 FLOW CYTOMETRY MARKET, BY REGION, 2021–2028 (USD MILLION) 217

10.2 NORTH AMERICA 218
FIGURE 29 NORTH AMERICA: FLOW CYTOMETRY MARKET SNAPSHOT 219
TABLE 211 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 220
TABLE 212 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 220
TABLE 213 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 220
TABLE 214 NORTH AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 215 NORTH AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY PRICE RANGE, 2021–2028 (USD MILLION) 221
TABLE 216 NORTH AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY PRICE RANGE, 2021–2028 (USD MILLION) 221
TABLE 217 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 222
TABLE 218 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 219 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 220 NORTH AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 221 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 224
10.2.1 US 224
10.2.1.1 High incidence of cancer and HIV/AIDS to drive market 224
TABLE 222 US: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 225
TABLE 223 US: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 225
TABLE 224 US: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 225 US: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 226 US: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 226
TABLE 227 US: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 227
TABLE 228 US: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 229 US: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 230 US: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 231 US: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 229
10.2.2 CANADA 229
10.2.2.1 Ongoing government initiatives for life sciences research to propel market 229
TABLE 232 CANADA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 230
TABLE 233 CANADA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 230
TABLE 234 CANADA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 235 CANADA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 236 CANADA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 231
TABLE 237 CANADA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 232
TABLE 238 CANADA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 239 CANADA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 240 CANADA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 241 CANADA: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 234
10.2.3 NORTH AMERICA: RECESSION IMPACT 234
10.3 EUROPE 235
TABLE 242 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 235
TABLE 243 EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 236
TABLE 244 EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 236
TABLE 245 EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 236
TABLE 246 EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 247 EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 237
TABLE 248 EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 237
TABLE 249 EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 250 EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 238
TABLE 251 EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 239
TABLE 252 EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 239
10.3.1 GERMANY 239
10.3.1.1 Strong base for R&D and growing awareness initiatives on flow cytometry to drive market 239
TABLE 253 GERMANY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 240
TABLE 254 GERMANY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 240
TABLE 255 GERMANY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 256 GERMANY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 257 GERMANY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 241
TABLE 258 GERMANY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 242
TABLE 259 GERMANY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 242
TABLE 260 GERMANY: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 261 GERMANY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 243
TABLE 262 GERMANY: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 244
10.3.2 UK 244
10.3.2.1 Increasing academic initiatives for cancer research to propel market 244
TABLE 263 UK: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 245
TABLE 264 UK: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 245
TABLE 265 UK: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 266 UK: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 267 UK: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 246
TABLE 268 UK: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 247
TABLE 269 UK: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 247
TABLE 270 UK: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 271 UK: FLOW CYTOMETRY MARKET FOR BY CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 248
TABLE 272 UK: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 249
10.3.3 FRANCE 249
10.3.3.1 Rising government funding for proteomics & genomics research to drive market 249
TABLE 273 FRANCE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 250
TABLE 274 FRANCE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 250
TABLE 275 FRANCE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 250
TABLE 276 FRANCE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 277 FRANCE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 251
TABLE 278 FRANCE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 251
TABLE 279 FRANCE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 280 FRANCE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 252
TABLE 281 FRANCE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 253
TABLE 282 FRANCE: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 253
10.3.4 ITALY 253
10.3.4.1 Increasing investments in life science research to drive market 253
TABLE 283 ITALY: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 254
TABLE 284 ITALY: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 254
TABLE 285 ITALY: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 286 ITALY: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 287 ITALY: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255
TABLE 288 ITALY: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 256
TABLE 289 ITALY: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 256
TABLE 290 ITALY: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 291 ITALY: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 257
TABLE 292 ITALY: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 258
10.3.5 SPAIN 258
10.3.5.1 Rising focus on cancer biomarkers to fuel market 258
TABLE 293 SPAIN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 259
TABLE 294 SPAIN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 259
TABLE 295 SPAIN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 259
TABLE 296 SPAIN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 297 SPAIN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 260
TABLE 298 SPAIN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 260
TABLE 299 SPAIN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 300 SPAIN: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 261
TABLE 301 SPAIN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 262
TABLE 302 SPAIN: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 262
10.3.6 REST OF EUROPE 262
TABLE 303 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 263
TABLE 304 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 263
TABLE 305 REST OF EUROPE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 264
TABLE 306 REST OF EUROPE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 264
TABLE 307 REST OF EUROPE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 264
TABLE 308 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 265
TABLE 309 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 265
TABLE 310 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 311 REST OF EUROPE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 266
TABLE 312 REST OF EUROPE: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 267
10.3.7 EUROPE: RECESSION IMPACT 267
10.4 ASIA PACIFIC 268
FIGURE 30 ASIA PACIFIC: FLOW CYTOMETRY MARKET SNAPSHOT 269
TABLE 313 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 270
TABLE 314 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 270
TABLE 315 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 271
TABLE 316 ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 317 ASIA PACIFIC: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 271
TABLE 318 ASIA PACIFIC: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 272
TABLE 319 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 272
TABLE 320 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 273
TABLE 321 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY, 2021–2028 (USD MILLION) 273
TABLE 322 ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 274
TABLE 323 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 274
10.4.1 JAPAN 275
10.4.1.1 Growing focus on development of advanced single-cell therapies to drive market 275
TABLE 324 JAPAN: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 275
TABLE 325 JAPAN: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 276
TABLE 326 JAPAN: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 327 JAPAN: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 276
TABLE 328 JAPAN: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 277
TABLE 329 JAPAN: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 277
TABLE 330 JAPAN: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 278
TABLE 331 JAPAN: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 278
TABLE 332 JAPAN: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 279
TABLE 333 JAPAN: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 279
10.4.2 CHINA 280
10.4.2.1 High Incidence of target diseases and increasing focus on personalized medicine to drive market 280
TABLE 334 CHINA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 280
TABLE 335 CHINA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 281
TABLE 336 CHINA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 337 CHINA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 281
TABLE 338 CHINA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 282
TABLE 339 CHINA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 282
TABLE 340 CHINA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 283
TABLE 341 CHINA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 283
TABLE 342 CHINA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 284
TABLE 343 CHINA: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 284
10.4.3 INDIA 284
10.4.3.1 Rising government funding for research in proteomics technologies to drive market 284
TABLE 344 INDIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 285
TABLE 345 INDIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 286
TABLE 346 INDIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 347 INDIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286
TABLE 348 INDIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 287
TABLE 349 INDIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 287
TABLE 350 INDIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 288
TABLE 351 INDIA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 288
TABLE 352 INDIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 289
TABLE 353 INDIA: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 289
10.4.4 AUSTRALIA 290
10.4.4.1 Increasing investments in life sciences research to support market growth 290
TABLE 354 AUSTRALIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 291
TABLE 355 AUSTRALIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 291
TABLE 356 AUSTRALIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 291
TABLE 357 AUSTRALIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 292
TABLE 358 AUSTRALIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 292
TABLE 359 AUSTRALIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 292
TABLE 360 AUSTRALIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 361 AUSTRALIA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 293
TABLE 362 AUSTRALIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 294
TABLE 363 AUSTRALIA: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 294
10.4.5 SOUTH KOREA 294
10.4.5.1 Rising growth in biotech industry to propel market 294
TABLE 364 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 295
TABLE 365 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 295
TABLE 366 SOUTH KOREA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 296
TABLE 367 SOUTH KOREA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 296
TABLE 368 SOUTH KOREA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 296
TABLE 369 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 297
TABLE 370 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 297
TABLE 371 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 298
TABLE 372 SOUTH KOREA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 298
TABLE 373 SOUTH KOREA: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 299
10.4.6 SINGAPORE 299
10.4.6.1 Launch of novel technologies for flow cytometry research to support market growth 299
TABLE 374 SINGAPORE: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 300
TABLE 375 SINGAPORE: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 300
TABLE 376 SINGAPORE: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 300
TABLE 377 SINGAPORE: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 301
TABLE 378 SINGAPORE: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 301
TABLE 379 SINGAPORE: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 301
TABLE 380 SINGAPORE: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 381 SINGAPORE: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 302
TABLE 382 SINGAPORE: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 303
TABLE 383 SINGAPORE: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 303
10.4.7 INDONESIA 304
10.4.7.1 Increasing collaborations between academic institutes for stem cell research to drive market 304
TABLE 384 INDONESIA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 304
TABLE 385 INDONESIA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 305
TABLE 386 INDONESIA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 387 INDONESIA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 305
TABLE 388 INDONESIA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 306
TABLE 389 INDONESIA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 306
TABLE 390 INDONESIA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 391 INDONESIA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 307
TABLE 392 INDONESIA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 308
TABLE 393 INDONESIA: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 308
10.4.8 REST OF ASIA PACIFIC 308
TABLE 394 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 309
TABLE 395 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 309
TABLE 396 REST OF ASIA PACIFIC: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 309
TABLE 397 REST OF ASIA PACIFIC: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 310
TABLE 398 REST OF ASIA PACIFIC: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 310
TABLE 399 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 310
TABLE 400 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 401 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 311
TABLE 402 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 312
TABLE 403 REST OF ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 312
10.4.9 ASIA PACIFIC: RECESSION IMPACT 312
10.5 LATIN AMERICA 313
TABLE 404 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 313
TABLE 405 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 313
TABLE 406 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 314
TABLE 407 LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 408 LATIN AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 314
TABLE 409 LATIN AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 315
TABLE 410 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 315
TABLE 411 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 316
TABLE 412 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 316
TABLE 413 LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 317
TABLE 414 LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 317
10.5.1 BRAZIL 317
10.5.1.1 Government initiatives for advancements in scientific research to support market growth 317
TABLE 415 BRAZIL: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 318
TABLE 416 BRAZIL: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 318
TABLE 417 BRAZIL: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 318
TABLE 418 BRAZIL: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 419 BRAZIL: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 319
TABLE 420 BRAZIL: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 319
TABLE 421 BRAZIL: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 422 BRAZIL: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 320
TABLE 423 BRAZIL: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 321
TABLE 424 BRAZIL: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 321
10.5.2 MEXICO 321
10.5.2.1 Favorable trade agreements for flow cytometry instruments to propel market 321
TABLE 425 MEXICO: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 322
TABLE 426 MEXICO: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 322
TABLE 427 MEXICO: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 428 MEXICO: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 429 MEXICO: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323
TABLE 430 MEXICO: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 324
TABLE 431 MEXICO: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 324
TABLE 432 MEXICO: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 433 MEXICO: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 325
TABLE 434 MEXICO: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 326
10.5.3 REST OF LATIN AMERICA 326
TABLE 435 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 326
TABLE 436 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 327
TABLE 437 REST OF LATIN AMERICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 327
TABLE 438 REST OF LATIN AMERICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 327
TABLE 439 REST OF LATIN AMERICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 328
TABLE 440 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 328
TABLE 441 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 442 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 329
TABLE 443 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 330
TABLE 444 REST OF LATIN AMERICA: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 330
10.5.4 LATIN AMERICA: RECESSION IMPACT 330
10.6 MIDDLE EAST & AFRICA 331
10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 331
TABLE 445 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 331
TABLE 446 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 332
TABLE 447 MIDDLE EAST & AFRICA: FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 332
TABLE 448 MIDDLE EAST & AFRICA: FLOW CYTOMETRY CELL ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 332
TABLE 449 MIDDLE EAST & AFRICA: FLOW CYTOMETRY CELL SORTERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 333
TABLE 450 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 333
TABLE 451 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 334
TABLE 452 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY, BY TYPE, 2021–2028 (USD MILLION) 334
TABLE 453 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION) 335
TABLE 454 MIDDLE EAST & AFRICA: FLOW CYTOMETRY MARKET, BY END USER, 2021–2028 (USD MILLION) 335
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 335
11 COMPETITIVE LANDSCAPE 336
11.1 INTRODUCTION 336
FIGURE 31 FLOW CYTOMETRY MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 336
11.2 REVENUE SHARE ANALYSIS 337
FIGURE 32 FLOW CYTOMETRY MARKET: REVENUE SHARE ANALYSIS OF KEY PLAYERS (2022) 337
11.3 MARKET SHARE ANALYSIS 337
FIGURE 33 FLOW CYTOMETRY MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) 338
TABLE 455 FLOW CYTOMETRY MARKET: INTENSITY OF COMPETITIVE RIVALRY 338
11.4 COMPANY EVALUATION MATRIX 339
11.4.1 STARS 340
11.4.2 EMERGING LEADERS 340
11.4.3 PERVASIVE PLAYERS 340
11.4.4 PARTICIPANTS 340
FIGURE 34 FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 341
11.5 COMPETITIVE BENCHMARKING OF LEADING PLAYERS 342
11.5.1 COMPANY PRODUCT FOOTPRINT 342
TABLE 456 FLOW CYTOMETRY MARKET: PRODUCT FOOTPRINT ANALYSIS 342
11.5.2 COMPANY REGIONAL FOOTPRINT 343
TABLE 457 FLOW CYTOMETRY MARKET: REGIONAL FOOTPRINT ANALYSIS 343
11.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES 344
11.6.1 PROGRESSIVE COMPANIES 344
11.6.2 STARTING BLOCKS 344
11.6.3 RESPONSIVE COMPANIES 344
11.6.4 DYNAMIC COMPANIES 344
FIGURE 35 FLOW CYTOMETRY MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 345
11.7 COMPETITIVE BENCHMARKING OF STARTUPS/SMES 346
TABLE 458 FLOW CYTOMETRY MARKET: DETAILED LIST OF KEY STARTUPS/SMES (2022) 346
TABLE 459 FLOW CYTOMETRY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2022) 346
11.8 COMPETITIVE SCENARIO AND TRENDS 347
11.8.1 PRODUCT LAUNCHES 347
TABLE 460 FLOW CYTOMETRY MARKET: PRODUCT LAUNCHES (JANUARY 2020−JULY 2023) 347
11.8.2 DEALS 347
TABLE 461 FLOW CYTOMETRY MARKET: DEALS (JANUARY 2020−JUNE 2023) 347
11.8.3 OTHER DEVELOPMENTS 348
TABLE 462 FLOW CYTOMETRY MARKET: OTHER DEVELOPMENTS (JANUARY 2020–APRIL 2023) 348

12 COMPANY PROFILES 349
12.1 KEY PLAYERS 349
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 BD 349
TABLE 463 BD: BUSINESS OVERVIEW 349
FIGURE 36 BD: COMPANY SNAPSHOT (2022) 350
12.1.2 DANAHER CORPORATION 355
TABLE 464 DANAHER CORPORATION: BUSINESS OVERVIEW 355
FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 356
12.1.3 THERMO FISHER SCIENTIFIC, INC. 360
TABLE 465 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 360
FIGURE 38 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022) 361
12.1.4 AGILENT TECHNOLOGIES, INC. 366
TABLE 466 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 366
FIGURE 39 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 367
12.1.5 SONY BIOTECHNOLOGY INC. (SUBSIDIARY OF SONY CORPORATION) 370
TABLE 467 SONY CORPORATION: BUSINESS OVERVIEW 370
FIGURE 40 SONY CORPORATION: COMPANY SNAPSHOT (2022) 371
12.1.6 BIO-RAD LABORATORIES, INC. 373
TABLE 468 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 373
FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 374
12.1.7 MILTENYI BIOTEC 377
TABLE 469 MILTENYI BIOTEC: BUSINESS OVERVIEW 377
12.1.8 ENZO BIOCHEM, INC. 379
TABLE 470 ENZO BIOCHEM, INC.: BUSINESS OVERVIEW 379
FIGURE 42 ENZO BIOCHEM, INC.: COMPANY SNAPSHOT (2022) 380
12.1.9 SYSMEX CORPORATION 382
TABLE 471 SYSMEX CORPORATION: BUSINESS OVERVIEW 382
FIGURE 43 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022) 383
12.1.10 BIOMÉRIEUX 386
TABLE 472 BIOMÉRIEUX: BUSINESS OVERVIEW 386
FIGURE 44 BIOMÉRIEUX: COMPANY SNAPSHOT (2022) 387
12.1.11 CYTONOME/ST, LLC. 388
TABLE 473 CYTONOME/ST, LLC.: BUSINESS OVERVIEW 388
12.1.12 SARTORIUS AG 389
TABLE 474 SARTORIUS AG: BUSINESS OVERVIEW 389
FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2022) 390
12.1.13 CYTEK BIOSCIENCES 392
TABLE 475 CYTEK BIOSCIENCES: BUSINESS OVERVIEW 392
FIGURE 46 CYTEK BIOSCIENCES: COMPANY SNAPSHOT (2022) 393
12.1.14 UNION BIOMETRICA, INC. 396
TABLE 476 UNION BIOMETRICA, INC.: BUSINESS OVERVIEW 396
12.1.15 LUMINEX CORPORATION (A DIASORIN COMPANY) 397
TABLE 477 DIASORIN S.P.A.: BUSINESS OVERVIEW 397
FIGURE 47 DIASORIN S.P.A.: COMPANY SNAPSHOT (2022) 398
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 400
12.2.1 APOGEE FLOW SYSTEMS LTD. 400
12.2.2 STRATEDIGM, INC. 400
12.2.3 NANOCELLECT BIOMEDICAL, INC. 402
12.2.4 ON-CHIP BIOTECHNOLOGIES CO., LTD. 403
12.2.5 NEXCELOM BIOSCIENCE LLC. 404
12.2.6 BENNUBIO, INC. 405
12.2.7 ORFLO TECHNOLOGIES 405
12.2.8 BAY BIOSCIENCES LLC. 406
12.2.9 CYTOBUOY B.V. 406
12.2.10 BIOLEGEND, INC. 407
13 APPENDIX 408
13.1 DISCUSSION GUIDE 408
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 413
13.3 CUSTOMIZATION OPTIONS 415
13.4 RELATED REPORTS 415
13.5 AUTHOR DETAILS 416

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ フローサイトメトリーの世界市場予測（～2028）：技術別、製品＆サービス別、用途別、エンドユーザー別、地域別(Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application ((Research - Immunology, Stem cell), (Clinical - Hematology)), End User & Region - Global Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

フローサイトメトリーの世界市場予測（～2028）：技術別、製品＆サービス別、用途別、エンドユーザー別、地域別

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp